@reginaldp - The FDA will highly likely be going through the process and tests indicated in the guidance I quoted, among other things, in my post in order to assess the resubmitted BLA. I simply can’t see, with the work having been done which was the subject of a lot of reasonable guesses here and which was reported elsewhere such as by Bell P, that the resubmission would have been done in any way other than as guided very explicitly by such guidances and draft guidances.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17915
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.8¢ |
Change
-0.013(1.29%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $1.969M | 2.039M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 11530 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 67069 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 14172 | 0.955 |
21 | 104529 | 0.950 |
19 | 250762 | 0.945 |
18 | 289023 | 0.940 |
12 | 332620 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 66018 | 21 |
0.965 | 115275 | 18 |
0.970 | 176956 | 16 |
0.975 | 180164 | 11 |
0.980 | 218794 | 8 |
Last trade - 14.02pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online